| scholarly article | Q13442814 |
| P50 | author | Nisha J Garg | Q87605053 |
| Nandadeva Lokugamage | Q117812116 | ||
| P2093 | author name string | Carolina Davies | |
| Subhadip Choudhuri | |||
| Imran Hussain Chowdhury | |||
| P2860 | cites work | The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease | Q22065799 |
| Chagas disease: an overview of clinical and epidemiological aspects | Q27003100 | ||
| MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis | Q27339129 | ||
| Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. | Q30372481 | ||
| Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice | Q33656471 | ||
| CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development? | Q33914939 | ||
| Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs | Q33916310 | ||
| Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats | Q33921202 | ||
| Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease | Q34563670 | ||
| TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice | Q34651261 | ||
| Markers of oxidative stress in adipose tissue during Trypanosoma cruzi infection | Q35218544 | ||
| Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis. | Q53245133 | ||
| PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance. | Q55416701 | ||
| Comparative evaluation of therapeutic DNA vaccines againstTrypanosoma cruziin mice | Q57200988 | ||
| Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice | Q57200990 | ||
| Pathology and Pathogenesis of Chagas Heart Disease | Q57789637 | ||
| Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking | Q64121308 | ||
| Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress | Q88988590 | ||
| Immunity and vaccine development efforts against Trypanosoma cruzi | Q90077254 | ||
| Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease | Q91069606 | ||
| MMP-12-Induced Pro-osteogenic Responses in Human Aortic Valve Interstitial Cells | Q91257106 | ||
| Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF-β as Tissue Remodelling Players | Q92309063 | ||
| Origin of Monocytes/Macrophages Contributing to Chronic Inflammation in Chagas Disease: SIRT1 Inhibition of FAK-NFκB-Dependent Proliferation and Proinflammatory Activation of Macrophages | Q92440999 | ||
| Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy | Q93353831 | ||
| NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease | Q35230292 | ||
| Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model | Q35325232 | ||
| Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease. | Q35569849 | ||
| A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi | Q35581314 | ||
| Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression | Q35663668 | ||
| SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease | Q36169626 | ||
| Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi | Q36429150 | ||
| Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant response | Q36519814 | ||
| Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice | Q36844866 | ||
| DNA Vaccines against Protozoan Parasites: Advances and Challenges | Q36915067 | ||
| Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease | Q37190915 | ||
| MnSODtg mice control myocardial inflammatory and oxidative stress and remodeling responses elicited in chronic Chagas disease | Q37328752 | ||
| Chemotherapeutic efficacy of phosphodiesterase inhibitors in chagasic cardiomyopathy. | Q37341337 | ||
| Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production | Q37398200 | ||
| 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis | Q37468730 | ||
| Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening | Q37582887 | ||
| Mechanisms of cardiac fibrosis in inflammatory heart disease. | Q37743971 | ||
| Vaccine development against Trypanosoma cruzi and Chagas disease. | Q37912537 | ||
| Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial | Q39146653 | ||
| Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy | Q39269382 | ||
| Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells | Q39836484 | ||
| Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways | Q40564183 | ||
| The Role of Sirtuins in Antioxidant and Redox Signaling | Q46309280 | ||
| Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. | Q46613780 | ||
| New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis | Q47104080 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| immunotherapy | Q1427096 | ||
| Chagas cardiomyopathy | Q18967247 | ||
| P577 | publication date | 2020-02-21 | |
| P1433 | published in | Vaccines | Q27725508 |
| P1476 | title | Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of Trypanosoma cruzi Infection | |
| P478 | volume | 8 |
Search more.